Along the same line, Enterococcus faecalis SF68, a lactic acid bacterium indigenous to the mammalian commensal microbiota, has also been suggested as a potential probiotic treatment for Giardia. Oral administration of this strain prior to G. lamblia infection led to elevated levels of total IgA levels in small intestine during the acute stage of infection, as well as higher levels of specific anti-Giardia IgA and systemic IgG compared to control animals. The gene discussed is CD79A; the disease is infection.